Identification of two distinct populations of endothelial progenitor cells differing in size and antigen expression from human umbilical cord blood
- PMID: 17909801
- DOI: 10.1007/s00277-007-0381-8
Identification of two distinct populations of endothelial progenitor cells differing in size and antigen expression from human umbilical cord blood
Abstract
Endothelial progenitor cells (EPCs) have been isolated from peripheral blood, bone marrow, and umbilical cord blood (CB) and determined to be in heterogeneous populations; however, specific variations in their characteristics remain to be clarified. In this study, we observed that mononuclear cells (MNCs) of CB change in morphology to differentiate into mature endothelial cells (EC) after 6 weeks of culture. In early days of culture along with the differentiation, two distinct populations of EPCs were detected, defined by two-dimensional dot plots (forward scatter vs side scatter) with flow cytometry, namely, relatively small cells (S-EPCs) and relatively large cells (L-EPCs). S-EPCs were found to express CD34 but not CD14, while the converse was the case for L-EPCs. When CD34(+)/CD14(-) cells and CD34(-)/CD14(+) cells were isolated from original MNCs of CB and cultured independently, S-EPCs and L-EPCs were derived from CD34(+)/CD14(-) and from CD34(-)/CD14(+) cells, respectively. Furthermore, when the two EPCs at day 7 were separated by cell sorter and recultured, there was no crossover in terms of CD34 and CD14 expression. While expression of VE-cadherin and vascular endothelial growth factor receptor-2 (VEGFR-2) on L-EPCs was significantly greater than on S-EPCs, levels of CD31 were lower. In addition, L-EPCs exhibited greater proliferative ability on stimulation with VEGF. Although these two EPCs expressed different phenotypes, including growth factor receptors, and had different proliferative ability, they both eventually differentiated into mature ECs after more than 3 weeks of culture.
Similar articles
-
Angiogenic potential difference between two types of endothelial progenitor cells from human umbilical cord blood.Cell Biol Int. 2006 Dec;30(12):1018-27. doi: 10.1016/j.cellbi.2006.08.002. Epub 2006 Aug 24. Cell Biol Int. 2006. PMID: 17020809
-
In vitro differentiation characteristics of cultured human mononuclear cells-implications for endothelial progenitor cell biology.Biochem Biophys Res Commun. 2005 Jul 29;333(2):476-82. doi: 10.1016/j.bbrc.2005.05.153. Biochem Biophys Res Commun. 2005. PMID: 15961064
-
Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.Biol Blood Marrow Transplant. 2006 May;12(5):585-93. doi: 10.1016/j.bbmt.2005.12.037. Biol Blood Marrow Transplant. 2006. PMID: 16635794
-
Transplantation of umbilical cord blood-derived endothelial progenitor cells: a promising method of therapeutic revascularisation.Eur J Haematol. 2006 Jan;76(1):1-8. doi: 10.1111/j.1600-0609.2005.00579.x. Eur J Haematol. 2006. PMID: 16343265 Review.
-
The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia.J Cell Physiol. 2009 May;219(2):235-42. doi: 10.1002/jcp.21672. J Cell Physiol. 2009. PMID: 19115244 Review.
Cited by
-
CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling.Stem Cells. 2009 Dec;27(12):3074-81. doi: 10.1002/stem.222. Stem Cells. 2009. PMID: 19785013 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials